Supercharged immune cells take aim at Virus-Linked cancers
NCT ID NCT03578406
Summary
This early-stage trial tested a new type of cell therapy for cancers caused by HPV, a common virus. Researchers gave patients specially engineered immune cells designed to find and attack cancer cells. The main goal was to find the safest and most effective dose of these cells, testing them in a small group of nine people with advanced cervical or head and neck cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Qingzhu Jia
Chongqing, Chongqing Municipality, 400037, China
Conditions
Explore the condition pages connected to this study.